CoreAge Rx vs TelePeptide
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and TelePeptide head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 67 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make TelePeptide a bad call — it's best for readers choosing between monthly and prepaid compounded care who want explicit totals and will confirm the charge and refund agreement. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | TelePeptide |
|---|---|---|
| Brief Score | 94/100 (A) | 67/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | $199/month for injections Annual plan: $2,028 upfront, equivalent to $169/month. Compounded medication, evaluation and shipping advertised as included; oral and microdose plans are separate. Full price detailsCompounded semaglutide injection advertised at $199/month; annual $2,028 upfront ($169/month equivalent); oral tablet is a separate plan; earlier listing: From $199/mo (starting dose, annual plan, compounded oral) |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | $249/month for injections Annual plan: $2,568 upfront, equivalent to $214/month. Compounded medication, evaluation and shipping advertised as included; oral and microdose plans are separate. Full price detailsCompounded tirzepatide injection advertised at $249/month; annual $2,568 upfront ($214/month equivalent); oral tablet is a separate plan; earlier listing: From $219/mo (starting dose, annual plan, compounded oral) |
| Coverage | US only; restrictions by state, confirmed at intake | Advertises forty-eight states and DC, excluding Alaska and Mississippi; actual clinician and pharmacy eligibility still applies |
| Brand-name access | Not confirmed | The site expressly describes compounded programs and says it does not supply FDA-approved branded GLP-1 medications. |
| Oral / sublingual | Injection only | Yes |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
TelePeptide: Injectable monthly rates are $199 semaglutide and $249 tirzepatide; annual prepays are $2,028/$2,568. Oral and microdose plans have separate prices.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.